Mary Beth Harler - 23 Jul 2025 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Executive Officer, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
23 Jul 2025
Net transactions value
-$18,457
Form type
4
Filing time
25 Jul 2025, 19:03:14 UTC
Previous filing
20 Jun 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harler Mary Beth Chief Executive Officer, Director C/O IGM BIOSCIENCES, INC., 3 EAST THIRD AVENUE, SUITE 200, SAN MATEO /s/ Misbah Tahir, by power of attorney 25 Jul 2025 0002018699

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Sale $18,457 -14,501 -4.3% $1.27 323,680 23 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $1.27 to $1.275. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price.